期刊
CANCER MANAGEMENT AND RESEARCH
卷 13, 期 -, 页码 2287-2294出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S298649
关键词
HCG18; miR-152-3p; RAB14; clear cell renal cell carcinoma
类别
资金
- Young Talent Development Plan of Changzhou Health Commission [CZQM2020049]
The study revealed that HCG18 was highly expressed in ccRCC and accelerated the development and progression of ccRCC by upregulating RAB14 via sponging miR-152-3p. This provides a potential therapeutic target for patients with ccRCC.
Background: Long noncoding RNAs (lncRNAs) have been regarded as crucial regulators in many cancers, including clear cell renal cell carcinoma (ccRCC). This research aimed to explore the biological role and molecular mechanism of lncRNA HCG18 in ccRCC. Materials and Methods: The expression levels of HCG18, miR-152-3p and RAB14 were examined by RT-qPCR. Cell viability, migration and invasion were examined by CCK-8 and transwell assays. Luciferase reporter and RIP assays were adopted to verify the interaction between miR-152-3p and HCG18 or RAB14. Results: It was found that HCG18 expression was highly expressed in ccRCC tissues and cells, and patients with high expression of HCG18 had a short overall survival time. Moreover, HCG18 depletion attenuated ccRCC cell viability, migration and invasion. In addition, miR-152-3p was confirmed as a downstream target of HCG18 and was inversely regulated by HCG18, and RAB14 was a target of miR-152-3p. Functional assays demonstrated that miR-152-3p silencing or RAB14 addition abolished the inhibitory effects of HCG18 knockdown on ccRCC progression. Conclusion: The results of the present study indicated that HCG18 accelerated the development and progression of ccRCC by upregulating RAB14 via sponging miR-152-3p, suggesting a potential therapeutic target for patients with ccRCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据